Strategic Partnerships VivoSense has recent collaboration activity with pharma and digital health partners, including Otsuka Group and Cambridge Cognition, signaling openness to joint development and embedded sensor data solutions for clinical trials and cognitive/physical function assessments.

Clinical Trial Focus The company emphasizes wearable sensor data management, device vetting, and DHT platform for compliant clinical trial data, presenting an opportunity to upsell end-to-end data integration, cleaning, and audit-ready reporting services to sponsors running studies.

Neurology & Sleep Focus Recent publications and projects around Alzheimer's disease, major depressive disorder, and digital sleep assessment tools indicate a strong specialty in neurologic and sleep-related endpoints that can be leveraged to target neuroscience and CNS trial customers.

Real World Evidence MEADOW-AD study and Digital Measures initiatives with real-world passively captured data suggest demand for scalable remote monitoring solutions, enabling conversations about longitudinal wearables programs and remote patient monitoring services.

Growth Readiness Revenue scale and leadership changes show momentum; with a lean team and notable partnerships, there is room to expand sales into larger CROs, pharma sponsors, and digital health platforms seeking validated sensor data capabilities and auditable analytics.